Bristol Myers Squibb Total Assets 2010-2024 | BMY

Bristol Myers Squibb total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bristol Myers Squibb total assets for the quarter ending March 31, 2024 were $99.031B, a 5.04% increase year-over-year.
  • Bristol Myers Squibb total assets for 2023 were $95.159B, a 1.72% decline from 2022.
  • Bristol Myers Squibb total assets for 2022 were $96.82B, a 11.43% decline from 2021.
  • Bristol Myers Squibb total assets for 2021 were $109.314B, a 7.74% decline from 2020.
Bristol Myers Squibb Annual Total Assets
(Millions of US $)
2023 $95,159
2022 $96,820
2021 $109,314
2020 $118,481
2019 $129,944
2018 $34,986
2017 $33,551
2016 $33,707
2015 $31,748
2014 $33,749
2013 $38,592
2012 $35,897
2011 $32,970
2010 $31,076
2009 $31,008
Bristol Myers Squibb Quarterly Total Assets
(Millions of US $)
2024-03-31 $99,031
2023-12-31 $95,159
2023-09-30 $91,263
2023-06-30 $93,489
2023-03-31 $94,281
2022-12-31 $96,820
2022-09-30 $98,196
2022-06-30 $100,357
2022-03-31 $103,034
2021-12-31 $109,314
2021-09-30 $110,893
2021-06-30 $110,797
2021-03-31 $112,435
2020-12-31 $118,481
2020-09-30 $125,536
2020-06-30 $128,076
2020-03-31 $129,285
2019-12-31 $129,944
2019-09-30 $57,433
2019-06-30 $55,163
2019-03-31 $34,834
2018-12-31 $34,986
2018-09-30 $33,734
2018-06-30 $32,641
2018-03-31 $33,083
2017-12-31 $33,551
2017-09-30 $33,977
2017-06-30 $33,409
2017-03-31 $32,937
2016-12-31 $33,707
2016-09-30 $33,727
2016-06-30 $32,831
2016-03-31 $31,892
2015-12-31 $31,748
2015-09-30 $31,779
2015-06-30 $31,954
2015-03-31 $33,579
2014-12-31 $33,749
2014-09-30 $33,450
2014-06-30 $33,503
2014-03-31 $33,424
2013-12-31 $38,592
2013-09-30 $36,804
2013-06-30 $36,252
2013-03-31 $35,958
2012-12-31 $35,897
2012-09-30 $36,044
2012-06-30 $31,667
2012-03-31 $32,408
2011-12-31 $32,970
2011-09-30 $32,014
2011-06-30 $31,833
2011-03-31 $30,851
2010-12-31 $31,076
2010-09-30 $31,885
2010-06-30 $31,051
2010-03-31 $30,753
2009-12-31 $31,008
2009-09-30 $30,951
2009-06-30 $29,809
2009-03-31 $29,693
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $84.996B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $165.308B 16.54
Vertex Pharmaceuticals (VRTX) United States $120.952B 31.12
Regeneron Pharmaceuticals (REGN) United States $116.041B 28.38
CSL (CSLLY) Australia $94.302B 0.00
Gilead Sciences (GILD) United States $88.044B 17.54
GSK (GSK) United Kingdom $83.894B 10.02
Moderna (MRNA) United States $51.124B 0.00
Biogen (BIIB) United States $32.614B 14.93
Argenex SE (ARGX) Netherlands $23.444B 0.00
Alnylam Pharmaceuticals (ALNY) United States $20.960B 0.00
BioNTech SE (BNTX) Germany $20.121B 169.28
Illumina (ILMN) United States $17.295B 123.38
Genmab (GMAB) Denmark $17.214B 20.18
BioMarin Pharmaceutical (BMRN) United States $15.908B 62.06
Sarepta Therapeutics (SRPT) United States $15.192B 1339.33
BeiGene (BGNE) Cayman Islands $14.959B 0.00
Incyte (INCY) United States $14.195B 21.95
Bio-Techne Corp (TECH) United States $11.608B 43.85
Insmed (INSM) United States $10.104B 0.00
QIAGEN (QGEN) Netherlands $9.553B 20.41
Exact Sciences (EXAS) United States $8.276B 0.00
Vaxcyte (PCVX) United States $8.153B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Intra-Cellular Therapies (ITCI) United States $8.085B 0.00
Roivant Sciences (ROIV) United Kingdom $7.897B 0.00
Legend Biotech (LEGN) United States $7.767B 0.00
Ascendis Pharma (ASND) Denmark $7.445B 0.00
Repligen (RGEN) United States $7.002B 91.47
Exelixis (EXEL) United States $6.731B 34.69
Halozyme Therapeutics (HALO) United States $6.561B 18.22
Blueprint Medicines (BPMC) United States $6.527B 0.00
Viking Therapeutics (VKTX) United States $5.816B 0.00
Zealand Pharma (ZLDPF) Denmark $5.746B 0.00
Cytokinetics (CYTK) United States $5.612B 0.00
Nuvalent (NUVL) United States $5.116B 0.00
ImmunityBio (IBRX) United States $5.021B 0.00
Krystal Biotech (KRYS) United States $4.993B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.776B 0.00
Apellis Pharmaceuticals (APLS) United States $4.620B 0.00
Alkermes (ALKS) Ireland $4.222B 16.52
Immunovant (IMVT) United States $3.990B 0.00
Avidity Biosciences (RNA) United States $3.730B 0.00
Axsome Therapeutics (AXSM) United States $3.628B 0.00
Guardant Health (GH) United States $3.617B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.292B 0.00
Denali Therapeutics (DNLI) United States $3.227B 0.00
Merus (MRUS) Netherlands $3.218B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.124B 0.00
Arcellx (ACLX) United States $3.003B 0.00
Amicus Therapeutics (FOLD) United States $2.989B 0.00
Twist Bioscience (TWST) United States $2.968B 0.00
Biohaven (BHVN) United States $2.963B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.829B 0.00
IDEAYA Biosciences (IDYA) United States $2.800B 0.00
Geron (GERN) United States $2.758B 0.00
MorphoSys AG (MOR) Germany $2.741B 0.00
SpringWorks Therapeutics (SWTX) United States $2.676B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.553B 0.00
ADMA Biologics Inc (ADMA) United States $2.550B 100.00
ACADIA Pharmaceuticals (ACAD) United States $2.528B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.455B 0.00
Intellia Therapeutics (NTLA) United States $2.337B 0.00
Celldex Therapeutics (CLDX) United States $2.325B 0.00
Iovance Biotherapeutics (IOVA) United States $2.241B 0.00
Apogee Therapeutics (APGE) United States $2.221B 0.00
Myriad Genetics (MYGN) United States $2.196B 0.00
Certara (CERT) United States $2.194B 50.52
Vericel (VCEL) United States $2.187B 0.00
Structure Therapeutics (GPCR) United States $2.124B 0.00
Janux Therapeutics (JANX) United States $2.124B 0.00
CG Oncology (CGON) United States $2.095B 0.00
Fortrea Holdings (FTRE) United States $2.070B 25.44
Rocket Pharmaceuticals (RCKT) United States $2.041B 0.00
Novavax (NVAX) United States $1.966B 0.00
Vera Therapeutics (VERA) United States $1.963B 0.00
Kymera Therapeutics (KYMR) United States $1.963B 0.00
Protagonist Therapeutics (PTGX) United States $1.892B 13.22
Beam Therapeutics (BEAM) United States $1.888B 0.00
Zai Lab (ZLAB) China $1.842B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.797B 0.00
Arvinas (ARVN) United States $1.726B 0.00
Bavarian Nordic (BVNRY) Denmark $1.723B 7.50
Harmony Biosciences Holdings (HRMY) United States $1.711B 13.04
Syndax Pharmaceuticals (SNDX) United States $1.704B 0.00
Galapagos (GLPG) Belgium $1.697B 0.00
NeoGenomics (NEO) United States $1.682B 0.00
Keros Therapeutics (KROS) United States $1.676B 0.00
Akero Therapeutics (AKRO) United States $1.604B 0.00
Kura Oncology (KURA) United States $1.595B 0.00
Edgewise Therapeutics (EWTX) United States $1.592B 0.00
Neumora Therapeutics (NMRA) United States $1.515B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.511B 0.00
Dynavax Technologies (DVAX) United States $1.496B 190.50
Arcus Biosciences (RCUS) United States $1.487B 0.00
Belite Bio (BLTE) United States $1.445B 0.00
Ligand Pharmaceuticals (LGND) United States $1.429B 23.35
Morphic Holding (MORF) United States $1.426B 0.00
MannKind (MNKD) United States $1.392B 170.33
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.320B 0.00
Vir Biotechnology (VIR) United States $1.244B 0.00
ANI Pharmaceuticals (ANIP) United States $1.228B 15.24
Sana Biotechnology (SANA) United States $1.220B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.212B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.195B 0.00
Prothena (PRTA) Ireland $1.155B 0.00
Disc Medicine (IRON) United States $1.092B 0.00
Tango Therapeutics (TNGX) United States $1.079B 0.00
Immatics (IMTX) Germany $1.047B 0.00
Nurix Therapeutics (NRIX) United States $1.047B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.019B 0.00
MiMedx (MDXG) United States $1.014B 42.94
Cullinan Therapeutics (CGEM) United States $1.005B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.985B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.983B 0.00
Spyre Therapeutics (SYRE) United States $0.971B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.938B 0.00
Liquidia Technologies (LQDA) United States $0.932B 0.00
Gyre Therapeutics (GYRE) United States $0.912B 0.00
Tyra Biosciences (TYRA) United States $0.897B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.878B 0.00
AbCellera Biologics (ABCL) Canada $0.853B 0.00
Abivax SA (ABVX) France $0.843B 0.00
Cogent Biosciences (COGT) United States $0.840B 0.00
89BIO (ETNB) United States $0.838B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.809B 0.00
Viridian Therapeutics (VRDN) United States $0.802B 0.00
Mesoblast (MESO) Australia $0.800B 0.00
Rapport Therapeutics (RAPP) $0.781B 0.00
PureTech Health (PRTC) United States $0.769B 0.00
Nuvation Bio (NUVB) United States $0.754B 0.00
Cytek Biosciences (CTKB) United States $0.752B 0.00
Dianthus Therapeutics (DNTH) United States $0.749B 0.00
Immunome (IMNM) United States $0.746B 0.00
Stoke Therapeutics (STOK) United States $0.742B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.739B 0.00
CureVac (CVAC) Germany $0.730B 0.00
Prime Medicine (PRME) United States $0.719B 0.00
Praxis Precision Medicines (PRAX) United States $0.713B 0.00
Scholar Rock Holding (SRRK) United States $0.674B 0.00
Pliant Therapeutics (PLRX) United States $0.663B 0.00
AnaptysBio (ANAB) United States $0.656B 0.00
Olema Pharmaceuticals (OLMA) United States $0.651B 0.00
HilleVax (HLVX) United States $0.650B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
WAVE Life Sciences (WVE) Singapore $0.643B 0.00
Humacyte (HUMA) United States $0.616B 0.00
GH Research (GHRS) Ireland $0.614B 0.00
Pharming Group (PHGUF) Netherlands $0.606B 0.00
ArriVent BioPharma (AVBP) United States $0.603B 0.00
Mineralys Therapeutics (MLYS) United States $0.598B 0.00
Zymeworks (ZYME) United States $0.595B 0.00
REGENXBIO (RGNX) United States $0.592B 0.00
Castle Biosciences (CSTL) United States $0.591B 0.00
CARGO Therapeutics (CRGX) United States $0.587B 0.00
Arbutus Biopharma (ABUS) United States $0.576B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Northwest Biotherapeutics (NWBO) United States $0.564B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.558B 0.00
Travere Therapeutics (TVTX) United States $0.557B 0.00
PepGen (PEPG) United States $0.553B 0.00
ITeos Therapeutics (ITOS) United States $0.535B 0.00
Allogene Therapeutics (ALLO) United States $0.533B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.527B 0.00
Replimune (REPL) United States $0.522B 0.00
Applied Therapeutics (APLT) United States $0.520B 0.00
Astria Therapeutics (ATXS) United States $0.518B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.517B 0.00
Third Harmonic Bio (THRD) United States $0.507B 0.00
Entrada Therapeutics (TRDA) United States $0.501B 23.57
Celcuity (CELC) United States $0.497B 0.00
Pharming Group (PHAR) Netherlands $0.490B 0.00
Oric Pharmaceuticals (ORIC) United States $0.487B 0.00
Avid Bioservices (CDMO) United States $0.479B 0.00
Contineum Therapeutics (CTNM) United States $0.478B 0.00
Adaptive Biotechnologies (ADPT) United States $0.477B 0.00
Oculis Holding AG (OCS) Switzerland $0.474B 0.00
Terns Pharmaceuticals (TERN) United States $0.468B 0.00
Annexon (ANNX) United States $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.456B 0.00
MaxCyte (MXCT) United States $0.443B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.441B 0.00
Alector (ALEC) United States $0.440B 0.00
Voyager Therapeutics (VYGR) United States $0.440B 0.00
IGM Biosciences (IGMS) United States $0.431B 0.00
Fate Therapeutics (FATE) United States $0.428B 0.00
Editas Medicine (EDIT) United States $0.420B 0.00
Fulcrum Therapeutics (FULC) United States $0.415B 0.00
Cabaletta Bio (CABA) United States $0.409B 0.00
Cartesian Therapeutics (RNAC) United States $0.406B 0.00
ACELYRIN, INC (SLRN) United States $0.404B 0.00
Neurogene (NGNE) United States $0.403B 0.00
AC Immune (ACIU) Switzerland $0.401B 0.00
EnGene Holdings (ENGN) United States $0.397B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.395B 0.00
Precigen (PGEN) United States $0.389B 0.00
Urogen Pharma (URGN) United States $0.387B 0.00
Anika Therapeutics (ANIK) United States $0.379B 325.00
Erasca (ERAS) United States $0.366B 0.00
Aura Biosciences (AURA) United States $0.357B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.356B 0.00
Molecular Partners AG (MOLN) Switzerland $0.352B 0.00
Anavex Life Sciences (AVXL) United States $0.345B 0.00
TScan Therapeutics (TCRX) United States $0.344B 0.00
Ocugen (OCGN) United States $0.342B 0.00
ALX Oncology Holdings (ALXO) United States $0.342B 0.00
Emergent Biosolutions (EBS) United States $0.342B 0.00
Absci (ABSI) United States $0.342B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.337B 0.00
Kyverna Therapeutics (KYTX) United States $0.333B 0.00
Jasper Therapeutics (JSPR) United States $0.333B 0.00
Scilex Holding (SCLX) United States $0.317B 0.00
Nautilus Biotechnology (NAUT) United States $0.307B 0.00
Agenus (AGEN) United States $0.306B 0.00
Alto Neuroscience (ANRO) United States $0.296B 0.00
C4 Therapeutics (CCCC) United States $0.292B 0.00
Atea Pharmaceuticals (AVIR) United States $0.290B 0.00
XOMA (XOMA) United States $0.285B 0.00
Amarin (AMRN) Ireland $0.283B 0.00
MeiraGTx Holdings (MGTX) United States $0.283B 0.00
Revance Therapeutics (RVNC) United States $0.278B 0.00
Inozyme Pharma (INZY) United States $0.275B 0.00
Kamada (KMDA) Israel $0.275B 20.78
Nkarta (NKTX) United States $0.272B 0.00
Poseida Therapeutics (PSTX) United States $0.270B 0.00
Sutro Biopharma (STRO) United States $0.264B 0.00
Mersana Therapeutics (MRSN) United States $0.261B 0.00
Solid Biosciences (SLDB) United States $0.248B 0.00
Tenaya Therapeutics (TNYA) United States $0.245B 0.00
CorMedix Inc (CRMD) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Renovaro (RENB) United States $0.232B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.226B 0.00
UniQure (QURE) Netherlands $0.223B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.220B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.219B 0.00
Inhibrx Biosciences (INBX) $0.219B 0.00
Skye Bioscience (SKYE) United States $0.218B 0.00
Inovio Pharmaceuticals (INO) United States $0.210B 0.00
Greenwich LifeSciences (GLSI) United States $0.210B 0.00
Rani Therapeutics Holdings (RANI) United States $0.209B 0.00
Shattuck Labs (STTK) United States $0.208B 0.00
23andMe Holding (ME) United States $0.208B 0.00
Codexis (CDXS) United States $0.207B 0.00
ChromaDex (CDXC) United States $0.206B 0.00
GENFIT S.A (GNFT) France $0.193B 0.00
Coherus BioSciences (CHRS) United States $0.192B 0.00
2seventy Bio (TSVT) United States $0.191B 0.00
Design Therapeutics (DSGN) United States $0.191B 0.00
Trevi Therapeutics (TRVI) United States $0.190B 0.00
Biomea Fusion (BMEA) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.188B 0.00
Q32 Bio (QTTB) United States $0.185B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.183B 0.00
Candel Therapeutics (CADL) United States $0.180B 0.00
Oncobiologics (OTLK) United States $0.179B 0.00
Ventyx Biosciences (VTYX) United States $0.177B 0.00
Innate Pharma S.A (IPHA) France $0.173B 0.00
Compugen (CGEN) Israel $0.171B 0.00
X4 Pharmaceuticals (XFOR) United States $0.170B 0.00
Alimera Sciences (ALIM) United States $0.165B 0.00
Rezolute (RZLT) United States $0.159B 0.00
XBiotech (XBIT) United States $0.157B 0.00
Caribou Biosciences (CRBU) United States $0.155B 0.00
FibroBiologics (FBLG) United States $0.155B 0.00
Lifecore Biomedical (LFCR) United States $0.152B 0.00
Compass Therapeutics (CMPX) United States $0.151B 0.00
Repare Therapeutics (RPTX) Canada $0.150B 0.00
Syros Pharmaceuticals (SYRS) United States $0.149B 0.00
Zura Bio (ZURA) United States $0.149B 0.00
Invivyd (IVVD) United States $0.148B 0.00
Gossamer Bio (GOSS) United States $0.147B 0.00
INmune Bio (INMB) United States $0.147B 0.00
ScPharmaceuticals (SCPH) United States $0.145B 0.00
Vigil Neuroscience (VIGL) United States $0.145B 0.00
Puma Biotechnology (PBYI) United States $0.144B 9.06
Inventiva S.A (IVA) France $0.140B 0.00
Elevation Oncology (ELEV) United States $0.140B 0.00
Adverum Biotechnologies (ADVM) United States $0.140B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.139B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.139B 0.00
Kodiak Sciences (KOD) United States $0.139B 0.00
BioStem Technologies (BSEM) $0.136B 0.00
Adagene (ADAG) China $0.136B 0.00
I-Mab (IMAB) China $0.136B 0.00
Adlai Nortye (ANL) Cayman Islands $0.135B 0.00
TELA Bio (TELA) United States $0.134B 0.00
Omega Therapeutics (OMGA) United States $0.134B 0.00
Semper Paratus Acquisition (TVGN) United States $0.133B 0.00
G1 Therapeutics (GTHX) United States $0.130B 0.00
Nuvectis Pharma (NVCT) United States $0.129B 0.00
Werewolf Therapeutics (HOWL) United States $0.125B 0.00
CervoMed (CRVO) United States $0.123B 0.00
Sagimet Biosciences (SGMT) United States $0.119B 0.00
Seres Therapeutics (MCRB) United States $0.118B 0.00
Opthea (OPT) Australia $0.117B 0.00
Akoya Biosciences (AKYA) United States $0.117B 0.00
Adicet Bio (ACET) United States $0.113B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.111B 0.00
Seer (SEER) United States $0.110B 0.00
Rapt Therapeutics (RAPT) United States $0.110B 0.00
Cardiff Oncology (CRDF) United States $0.110B 0.00
Boundless Bio (BOLD) United States $0.106B 0.00
Cellectis S.A (CLLS) France $0.105B 0.00
ATyr Pharma (ATYR) United States $0.103B 0.00
CytomX Therapeutics (CTMX) United States $0.101B 6.45
Immunic (IMUX) United States $0.100B 0.00
BeyondSpring (BYSI) United States $0.099B 0.00
BioHarvest Sciences (CNVCD) Canada $0.099B 0.00
Bluebird Bio (BLUE) United States $0.098B 0.00
Allakos (ALLK) United States $0.098B 0.00
PDS Biotechnology (PDSB) United States $0.097B 0.00
DBV Technologies S.A (DBVT) France $0.094B 0.00
Sangamo Therapeutics (SGMO) United States $0.092B 0.00
InflaRx (IFRX) Germany $0.091B 0.00
VistaGen Therapeutics (VTGN) United States $0.091B 0.00
Athira Pharma (ATHA) United States $0.090B 0.00
Affimed (AFMD) Germany $0.089B 0.00
Coya Therapeutics (COYA) United States $0.088B 0.00
Eton Pharmaceuticals (ETON) United States $0.086B 83.50
Elutia (ELUT) United States $0.085B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.082B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Vor Biopharma (VOR) $0.081B 0.00
Clearside Biomedical (CLSD) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.081B 0.00
Verastem (VSTM) United States $0.080B 0.00
IO Biotech (IOBT) Denmark $0.078B 0.00
Gritstone Bio (GRTS) United States $0.078B 0.00
Oncolytics Biotech (ONCY) Canada $0.077B 0.00
Connect Biopharma Holdings (CNTB) United States $0.077B 0.00
Cognition Therapeutics (CGTX) United States $0.076B 0.00
China Health Industries Holdings (CHHE) China $0.074B 0.00
Spero Therapeutics (SPRO) United States $0.074B 2.69
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
BioAtla (BCAB) United States $0.073B 0.00
Entera Bio (ENTX) Israel $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.071B 0.00
Genelux (GNLX) United States $0.071B 0.00
Galena Biopharma (SLS) United States $0.070B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.070B 0.00
Elicio Therapeutics (ELTX) United States $0.068B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.068B 0.00
Aileron Therapeutics (ALRN) United States $0.068B 0.00
Instil Bio (TIL) United States $0.067B 0.00
LENZ Therapeutics (LENZ) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
Annovis Bio (ANVS) United States $0.066B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.066B 0.00
Cue Biopharma (CUE) United States $0.066B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Earth Science Tech (ETST) United States $0.065B 0.00
Kronos Bio (KRON) United States $0.065B 0.00
Turnstone Biologics (TSBX) United States $0.065B 0.00
Benitec Biopharma (BNTC) United States $0.064B 0.00
Checkpoint Therapeutics (CKPT) United States $0.064B 0.00
HOOKIPA Pharma (HOOK) United States $0.064B 0.00
AN2 Therapeutics (ANTX) United States $0.063B 0.00
Rallybio (RLYB) United States $0.061B 0.00
Theratechnologies (THTX) Canada $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
CalciMedica (CALC) United States $0.058B 0.00
VTv Therapeutics (VTVT) United States $0.057B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Alpha Teknova (TKNO) United States $0.056B 0.00
Passage Bio (PASG) United States $0.056B 0.00
LakeShore Biopharma (LSB) China $0.056B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.055B 0.00
Ovid Therapeutics (OVID) United States $0.055B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.055B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Cidara Therapeutics (CDTX) United States $0.053B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.052B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Clene (CLNN) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.051B 0.00
Bionano Genomics (BNGO) United States $0.050B 0.00
Leap Therapeutics (LPTX) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
NextCure (NXTC) United States $0.045B 0.00
Aerovate Therapeutics (AVTE) United States $0.045B 0.00
Ocean Biomedical (OCEA) United States $0.045B 0.00
Beyond Air (XAIR) United States $0.045B 0.00
Lantern Pharma (LTRN) United States $0.045B 0.00
Dare Bioscience (DARE) United States $0.044B 0.00
BioXcel Therapeutics (BTAI) United States $0.043B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Aadi Bioscience (AADI) United States $0.042B 0.00
Ocuphire Pharma (OCUP) United States $0.041B 0.00
Atara Biotherapeutics (ATRA) United States $0.040B 0.00
IN8bio (INAB) United States $0.039B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.037B 0.00
Fortress Biotech (FBIO) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Aligos Therapeutics (ALGS) United States $0.035B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.035B 0.00
Eyenovia (EYEN) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Carmell (CTCX) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.032B 0.00
Quince Therapeutics (QNCX) United States $0.030B 0.00
NKGen Biotech (NKGN) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
Lisata Therapeutics (LSTA) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
HCW Biologics (HCWB) United States $0.027B 0.00
Cocrystal Pharma (COCP) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
Equillium (EQ) United States $0.023B 0.00
BRIACELL THERAP (BCTX) Canada $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.021B 0.00
Orgenesis (ORGS) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Apollomics (APLM) United States $0.018B 0.00
Lumos Pharma (LUMO) United States $0.018B 0.00
Forte Biosciences (FBRX) United States $0.018B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Sensei Biotherapeutics (SNSE) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
KALA BIO (KALA) United States $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Longeveron (LGVN) United States $0.014B 0.00
Aptose Biosciences (APTO) Canada $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Kintara Therapeutics (KTRA) United States $0.014B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.014B 0.00
Galecto (GLTO) Denmark $0.013B 0.00
Purple Biotech (PPBT) Israel $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.012B 0.00
Senti Biosciences (SNTI) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
AEterna Zentaris (AEZS) Canada $0.008B 0.00
Kineta (KA) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.006B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Tenax Therapeutics (TENX) United States $0.005B 0.00
TFF Pharmaceuticals (TFFP) United States $0.005B 0.00
GeoVax Labs (GOVX) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Trevena (TRVN) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Entero Therapeutics (ENTO) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Psyence Biomedical (PBM) United States $0.003B 0.00
Soligenix (SNGX) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
TRACON Pharmaceuticals (TCON) United States $0.003B 0.36
Invo BioScience (INVO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
CNS Pharmaceuticals (CNSP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00